Skip to main content

INSPIRE VETERINARY PARTNERS, INC.

corporate_fare Company Profile

INSPIRE VETERINARY PARTNERS, INC.

IVPR·OTC·Consumer Cyclical·CIK 0001939365

Inspire Veterinary owns and operates thirteen veterinary hospitals across nine states in the United States. The company specializes in small animal general practice hospitals, primarily serving canine and feline breeds, and also provides equine care. Services offered at its hospitals include preventive care for companion animals, such as annual health exams, parasite control, dental health, nutrition and body condition counseling, neurological examinations, radiology, bloodwork, skin and coat health, and breed-specific preventive care. Surgical offerings encompass soft tissue procedures like spays and neuters, mass removals, splenectomies, gastropexies, and orthopedic procedures, depending on the doctor's training. Many locations also provide additional care and alternative procedures such as acupuncture, chiropractic, and other health and wellness offerings. Inspire Veterinary expands by acquiring existing hospitals that demonstrate a financial track record, marketplace advantages, and future growth potential. The company's distributed leadership and support structure allows for acquisitions across various geographic areas. Inspire Veterinary completed its initial public offering on August 31, 2023, and its Class A Common Stock trades on The Nasdaq Capital Market under the symbol "IVP." The company was incorporated in Delaware in 2020 and converted to a Nevada c-corporation in June 2022. It has two consolidating holding companies, IVP Practice Holdings Co., LLC and IVP Real Estate Co., LLC, which are passive intermediate holding companies.

INSPIRE VETERINARY PARTNERS, INC. (OTC:IVPR) is a publicly traded company in the Consumer Cyclical sector. Wiseek has independently scored 4 items for IVPR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-03-02, rated 7/10. Across its 4 most recent items scored 7 or higher, the top rating is 9/10, with 3 rated 8 or above. Recent SEC coverage for IVPR spans 8-K, 424B3, S-1/A.

Recent high-impact activity:

  • Director Erinn Thomas-Mackey Resigns from Inspire Veterinary Partners Board Amidst Delisting and Dilution
  • Final Prospectus Details Resale of 200 Million Shares, Confirming Massive Dilution for Nano-Cap IVPR
  • Inspire Veterinary Partners Files S-1 for Resale of 200M Shares, Signaling Extreme Dilution Amidst Going Concern Warning
  • Inspire Veterinary Partners Delisted from Nasdaq, Moves to OTCQB Venture Market

Financial Snapshot

Fiscal year ended December 31, 2024
Revenue
$16.59M
Net Income
-$14.26M
Op. Cash Flow
-$10.01M
Free Cash Flow
-$10.24M
Operating Income
-$9.03M
Cash & Equivalents
$523.69K
Debt / Equity
0.00×
Net Margin
-86.0%
Source: 10-K · filed 2025-03-31 · accession 0001213900-25-026232

Short Interest & Short Volume

39.08 days to cover

FINRA reported short interest of 1,333,550 shares in IVPR as of the October 30, 2026 settlement, unchanged from the prior period — about 39.1 days to cover at its recent average daily volume.

Short interest (bi-monthly positions)1,333,550 shares as of October 30, 2026
Change vs prior period 0.0%
Days to cover39.08 at avg daily volume of 34,124

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

No longer listed

IVPR (INSPIRE VETERINARY PARTNERS, INC.) is no longer listed on a major US exchange, so Wiseek no longer shows market data for this symbol. It last appeared on NASDAQ. The filings and coverage below remain available as an archive.

feed IVPR - Latest Insights

IVPR
Mar 02, 2026, 12:53 PM EST
Filing Type: 8-K
Importance Score:
7
IVPR
Jan 30, 2026, 4:30 PM EST
Filing Type: 424B3
Importance Score:
9
IVPR
Jan 28, 2026, 4:27 PM EST
Filing Type: S-1/A
Importance Score:
9
IVPR
Jan 21, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
9
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets